These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 9420225)

  • 21. Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4.
    Cho MW; Lee MK; Carney MC; Berson JF; Doms RW; Martin MA
    J Virol; 1998 Mar; 72(3):2509-15. PubMed ID: 9499115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism.
    Kato K; Sato H; Takebe Y
    J Virol; 1999 Jul; 73(7):5520-6. PubMed ID: 10364300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment.
    Melikyan GB; Platt EJ; Kabat D
    Retrovirology; 2007 Aug; 4():55. PubMed ID: 17686153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.
    Catani MV; Corasaniti MT; Navarra M; Nisticò G; Finazzi-Agrò A; Melino G
    J Neurochem; 2000 Jun; 74(6):2373-9. PubMed ID: 10820198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains.
    Alfano M; Schmidtmayerova H; Amella CA; Pushkarsky T; Bukrinsky M
    J Exp Med; 1999 Sep; 190(5):597-605. PubMed ID: 10477545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry.
    Farzan M; Vasilieva N; Schnitzler CE; Chung S; Robinson J; Gerard NP; Gerard C; Choe H; Sodroski J
    J Biol Chem; 2000 Oct; 275(43):33516-21. PubMed ID: 10938094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events.
    Doranz BJ; Baik SS; Doms RW
    J Virol; 1999 Dec; 73(12):10346-58. PubMed ID: 10559353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.
    Hill CM; Deng H; Unutmaz D; Kewalramani VN; Bastiani L; Gorny MK; Zolla-Pazner S; Littman DR
    J Virol; 1997 Sep; 71(9):6296-304. PubMed ID: 9261346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins.
    Lin G; Baribaud F; Romano J; Doms RW; Hoxie JA
    J Virol; 2003 Jan; 77(2):931-42. PubMed ID: 12502809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variants of human immunodeficiency virus type 1 that efficiently use CCR5 lacking the tyrosine-sulfated amino terminus have adaptive mutations in gp120, including loss of a functional N-glycan.
    Platt EJ; Shea DM; Rose PP; Kabat D
    J Virol; 2005 Apr; 79(7):4357-68. PubMed ID: 15767436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor.
    Cormier EG; Dragic T
    J Virol; 2002 Sep; 76(17):8953-7. PubMed ID: 12163614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates.
    Chabot DJ; Zhang PF; Quinnan GV; Broder CC
    J Virol; 1999 Aug; 73(8):6598-609. PubMed ID: 10400757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in the V3 stem versus the V3 crown and C4 region have different effects on the binding and fusion steps of human immunodeficiency virus type 1 gp120 interaction with the CCR5 coreceptor.
    Suphaphiphat P; Essex M; Lee TH
    Virology; 2007 Mar; 360(1):182-90. PubMed ID: 17101166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated region.
    Platt EJ; Kuhmann SE; Rose PP; Kabat D
    J Virol; 2001 Dec; 75(24):12266-78. PubMed ID: 11711617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly conserved beta16/beta17 beta-hairpin structure in human immunodeficiency virus type 1 YU2 gp120 is critical for CCR5 binding.
    Mechulam A; Cerutti M; Pugnière M; Missé D; Gajardo J; Roquet F; Robinson J; Veas F
    J Mol Med (Berl); 2005 Jul; 83(7):542-52. PubMed ID: 15905975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of amino acid substitution of the V3 and bridging sheet residues in human immunodeficiency virus type 1 subtype C gp120 on CCR5 utilization.
    Suphaphiphat P; Thitithanyanont A; Paca-Uccaralertkun S; Essex M; Lee TH
    J Virol; 2003 Mar; 77(6):3832-7. PubMed ID: 12610158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-receptors for HIV-1 entry.
    Moore JP; Trkola A; Dragic T
    Curr Opin Immunol; 1997 Aug; 9(4):551-62. PubMed ID: 9287172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus.
    Platt EJ; Durnin JP; Kabat D
    J Virol; 2005 Apr; 79(7):4347-56. PubMed ID: 15767435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120.
    Cormier EG; Persuh M; Thompson DA; Lin SW; Sakmar TP; Olson WC; Dragic T
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5762-7. PubMed ID: 10823934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.